Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Trilostane

Trilostane

pharmaceutical raw materials
Trilostane structure

Trilostane 

structure
  • CAS No:

    13647-35-3

  • Formula:

    C20H27NO3

  • Chemical Name:

    Trilostane

  • Synonyms:

    Androst-2-ene-2-carbonitrile,4,5-epoxy-3,17-dihydroxy-,(4α,5α,17β)-;(4α,5α,17β)-4,5-Epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrile;Trilostane;Win 24540;Modrenal;Modrefen;Desopan;Modrastane;Vetoryl;27107-98-8;28414-46-2

  • Categories:

    Inorganic Chemistry  >  Inorganic Salts

Description

Tan CrystalsTrilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome and primary hyperaldosteronism. These are both disorders where excess amounts of corticosteroid hormones are produced in the body. Corticosteroids are essential for the body to make use of carbohydrates, fats and proteins and for a normal response to stress. They are also necessary for the regulation of salt and water balance in the body.


Solid


Trilostane is an epoxy steroid that is 3,17beta-dihydroxy-5alpha-androst-2-ene-2-carbonitrile in which the oxygen of the epoxy group is joined to the 4alpha and 5 alpha positions. It has a role as an antineoplastic agent, an abortifacient and an EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor. It is a 3-hydroxy steroid, a 17beta-hydroxy steroid, an androstanoid, an epoxy steroid and a nitrile.|Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It was withdrawn from the United States market in April 1994.|Trilostane is a synthetic derivative of androstane with adrenocortical suppressive properties. Trilostane reversibly inhibits 3 beta-hydroxysteroid dehydrogenase delta 5-4 isomerase in the adrenal cortex, resulting in the decreased synthesis of mineralocorticoids and glucocorticoids and the decreased conversion of pregnenolone to progesterone. (NCI04)

Trilostane Basic Attributes

329.43

329.43

237-133-0

L0FPV48Q5R

DTXSID9023706

C1263

H - Systemic hormonal preparations, excl. sex hormones and insulins

29372900

Characteristics

76.8

3

white to tan

1.1213 (rough estimate)

264 °C (decomp)

467.02°C (rough estimate)

254.8±28.7 °C

1.5614 (estimate)

DMSO: ≥17mg/mL

-20°C Freezer

D25 +137.4° (c = 1 in pyridine)

Safety Information

NONH for all modes of transport

3

36/37/38-62

26-36/37

Xi

P281-P305 + P351 + P338

H315-H319-H361

|Warning|H315 (97.73%): Causes skin irritation [Warning Skin corrosion/irritation]|P201, P202, P264, P280, P281, P302+P352, P305+P351+P338, P308+P313, P321, P332+P313, P337+P313, P362, P405, and P501|Aggregated GHS information provided by 44 companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

Symptoms of overdose include darkening of skin, drowsiness or tiredness, loss of appetite, mental depression, skin rash, and/or vomiting.

Drug Information

Used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.

Trilostane blocks an enzyme involved in the production of several steroids including cortisol. Inhibiting this enzyme inhibits the production of cortisol. In Cushing's syndrome, the adrenal gland overproduces steroids. Although steroids are important for various functions of the body, too much can cause problems. Trilostane reduces the amount of steroids produced by the adrenal gland. This product was withdrawn from the U.S. market in April 1994.

Steroidal compounds with abortifacient activity. (See all compounds classified as Abortifacient Agents, Steroidal.)|Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)|Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

Hepatic.

8 hours.

Trilostane produces suppression of the adrenal cortex by inhibiting enzymatic conversion of steroids by 3-beta-hydroxysteroid dehydrogenase/delta 5,4 ketosteroid isomerase, thus blocking synthesis of adrenal steroids.

4alpha,5-epoxy-17beta-hydroxy-3-oxoandrostane-2-carbonitrile

Trilostane Use and Manufacturing

Uses

antifungal, inhibits mitosis in metaphase

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients|Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients

Computed Properties

Molecular Weight:329.4
XLogP3:2.9
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Exact Mass:329.19909372
Monoisotopic Mass:329.19909372
Topological Polar Surface Area:76.8
Heavy Atom Count:24
Complexity:692
Defined Atom Stereocenter Count:8
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Trilostane

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.